Literature DB >> 11208607

Mechanisms of chloride transport in thymic lymphocytes.

D Stakisaitis1, M S Lapointe, D Batlle.   

Abstract

This study examined mechanisms of Cl- transport in rat lymphocytes under a variety of conditions. Basal intracellular Cl- concentration ([Cl-]i) was not different between cells assayed in the presence of HCO3- or its absence (HEPES). Removal of external Cl- resulted in a fall in [Cl-]i and a rapid rise in intracellular pH (pH(i)). Both Cl- efflux and the rise in pH(i) were blocked by DIDS or removal of external Na+ but were unaffected by furosemide. The mechanisms governing Cl- influx were assessed in cells that had been Cl- depleted for 1 h. Reexposure to Cl- resulted in a rapid rise in [Cl-]i that was partially inhibited by pretreatment with DIDS (57%) and partially inhibited by pretreatment with furosemide (45%). Pretreatment with both compounds together completely blocked Cl- influx. Cl- depletion caused a marked increase in pH(i) that rapidly declined toward normal when the cells were reexposed to Cl-. Preincubation with DIDS completely blocked this decrease in pH(i). In contrast, neither removal of Na+ nor preincubation with furosemide affected the decline in pH(i) when the cells were reexposed to Cl-. We conclude that, in thymic lymphocytes, Cl-/HCO3- (or Cl-/base exchange) regulates both Cl- influx and efflux. Cl- efflux is totally inhibited by DIDS and is mediated by a Na+-dependent Cl-/HCO3- exchanger. Cl- influx is partially DIDS sensitive and partially furosemide sensitive and is mediated by both a Na+-independent Cl-/HCO3- exchanger and by a Na+-K+-2Cl- cotransporter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11208607     DOI: 10.1152/ajprenal.2001.280.2.F314

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

Review 1.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

2.  Sodium Dichloroacetate Pharmacological Effect as Related to Na-K-2Cl Cotransporter Inhibition in Rats.

Authors:  Jūratė Stanevičiūtė; Milda Juknevičienė; Jolita Palubinskienė; Ingrida Balnytė; Angelija Valančiūtė; Rūta Vosyliūtė; Kęstutis Sužiedėlis; Vaiva Lesauskaitė; Donatas Stakišaitis
Journal:  Dose Response       Date:  2018-11-20       Impact factor: 2.658

3.  Gender-Related Effect of Sodium Dichloroacetate on the Number of Hassall's Corpuscles and RNA NKCC1 Expression in Rat Thymus.

Authors:  Jūratė Stanevičiūtė; Milda Juknevičienė; Ingrida Balnytė; Angelija Valančiūtė; Vaiva Lesauskaitė; Julija Fadejeva; Rimantas Stakauskas; Donatas Stakišaitis
Journal:  Biomed Res Int       Date:  2019-04-24       Impact factor: 3.411

4.  Valproic Acid Inhibits NA-K-2CL Cotransporter RNA Expression in Male But Not in Female Rat Thymocytes.

Authors:  Milda Juknevičienė; Ingrida Balnytė; Angelija Valančiūtė; Vaiva Lesauskaitė; Jurate Stanevičiūtė; Rūta Curkūnavičiūtė; Donatas Stakišaitis
Journal:  Dose Response       Date:  2019-05-30       Impact factor: 2.658

Review 5.  The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Eligija Damanskienė; Angelija Valančiūtė; Ingrida Balnytė; Marta Maria Alonso
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

6.  Sodium valproate stimulates potassium and chloride urinary excretion in rats: gender differences.

Authors:  Eitaute Jakutiene; Jurgita Grikiniene; Arunas Vaitkevicius; Marina Tschaika; Janina Didziapetriene; Donatas Stakisaitis
Journal:  BMC Pharmacol       Date:  2007-08-06

7.  Sodium is not required for chloride efflux via chloride/bicarbonate exchanger from rat thymic lymphocytes.

Authors:  Donatas Stakišaitis; Vaidevutis Meilus; Alfonsas Juška; Paulius Matusevičius; Janina Didžiapetrienė
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.